Patient Guide 9 min read July 2, 2026

Why Your GLP-1 Isn’t Working — And What to Fix

If you’re on a GLP-1 medication and something doesn’t feel right, you’re not alone. Here’s what actually goes wrong, why it happens, and what real clinical management looks like.

If you’re on a GLP-1 medication and something doesn’t feel right, you’re not alone. The clinic sees a steady stream of patients who started on semaglutide or tirzepatide through a telehealth service, an online mill, or even a well-intentioned local provider — and are now stuck. The nausea won’t stop. The weight isn’t moving anymore. The dose feels too high, or too low, or they can’t tell which. Their energy has crashed. They’re not sure who to ask.

What almost all of these situations have in common is this: nobody is actually managing the medication. A patient got a prescription, was told to inject weekly, and was left to figure out the rest. That’s not medicine. That’s a shipping service.

This guide is about what actually goes wrong with GLP-1 therapy, why it happens, and what real clinical management looks like — because when GLP-1s are managed correctly, they work remarkably well.

The most common reasons your GLP-1 isn’t working

Let’s start with the specific problems patients bring to us, in roughly the order we see them.

1. The dose is wrong for your stage

GLP-1s aren’t a one-size medication. Semaglutide starts at 0.25 mg weekly and can be titrated up to 2.4 mg. Tirzepatide starts at 2.5 mg and titrates up to 15 mg. The right dose depends on your body composition, how you’re tolerating the medication, how much progress you’ve made, and where you are in the timeline.

Many patients we see are stuck at doses that don’t match their stage. They started at a low dose, weight loss stalled at week 10, and nobody increased them. Or they’re at a high dose too early, which is why they can’t stop feeling nauseated.

The dose should evolve as you do. Real GLP-1 management means titration decisions based on your actual response — not a rigid schedule set the day you started.

2. Nausea and GI side effects that never resolved

Some early-treatment nausea is expected. What’s not normal is nausea that persists into month three or beyond, or nausea severe enough that you’re not eating enough protein, or nausea that limits your life.

When nausea persists, it usually means one of several things: the dose went up too fast, injection timing needs adjustment, or you need supportive medication and dietary strategies you weren’t taught. Most of these are fixable in a single consultation. Almost none of them get fixed when your prescriber is a website.

3. Weight loss stalled and nobody adjusted

Weight loss on GLP-1s isn’t linear. There are natural plateaus at week 8, at month 4, at month 6. Some are appropriate pause points; others are signals to change something. The signal difference matters.

If your weight stalled and you were told to “keep going” without any assessment — no lab work, no body composition check, no dosage discussion, no protein or resistance training conversation — you were left without guidance at the exact moment you needed it most.

4. You’re losing muscle, not just fat

This is one of the most under-discussed problems in GLP-1 care. Weight loss on these medications is not automatically fat loss. Without adequate protein intake, resistance training, and body composition monitoring, up to 40 percent of the weight you lose can be lean muscle. That’s a bad outcome even if the scale looks good.

We wrote a full article on this problem and how to prevent it because it matters that much.

5. Energy tanked and nothing feels right

If you’re eating dramatically less because of appetite suppression, and you weren’t given a nutrition plan to match, you’re probably nutrient-deficient at this point. Low energy on GLP-1s is almost always a downstream consequence of inadequate intake — not enough protein, not enough of the specific micronutrients (iron, B12, magnesium) that keep energy production working.

This is also fixable, but only if someone is actually looking. Standard telehealth GLP-1 programs don’t order labs. They don’t measure ferritin, thyroid, B12, or magnesium. They don’t know what’s happening inside your body — because they never checked.

6. You’re worried about what happens when you stop

This one comes up in almost every consultation. Patients on GLP-1s hear the horror stories about rebound weight gain, and they don’t know how to think about the medication long-term. Is this forever? Can they taper off? What happens after?

The honest answer is that GLP-1s are generally maintenance medications, not short-term interventions. But there are structured ways to transition, dose down, or extend to a lower maintenance dose that some patients tolerate very well. None of these strategies work without a clinician who’s actually planning your long-term course.

What GLP-1 management should actually look like

A real GLP-1 program isn’t a subscription to weekly shots. It’s a clinical relationship. Here’s what we do at The Tide, and what any legitimate program should look like.

Comprehensive workup before starting

Before you start a GLP-1, we should know your metabolic baseline, not just your BMI. If you don’t know where you’re starting, you can’t measure whether treatment is working. .

Body composition tracking, not just weight

Weight alone is the wrong metric for GLP-1 outcomes. We measure body composition — fat mass, lean mass, visceral fat — at baseline and at intervals during treatment. This is the only way to know whether the medication is doing the job you actually want it to do (fat loss) versus the job that just looks similar on the scale (weight loss including muscle).

Nutrition support built into the protocol

GLP-1 patients eat significantly less. Without a nutrition strategy, that reduced intake becomes nutrient deficiency. Every patient on a GLP-1 at The Tide gets clear protein targets, micronutrient guidance, and specific supplementation recommendations for their situation.

Titration based on your response, not a schedule

We adjust your dose based on what you’re actually experiencing — not what the box says. If you’re tolerating well and progress is steady, we may hold. If you’re stalled, we may increase. If you’re struggling, we may reduce. Every decision is a clinical one.

Follow-up that’s actually clinical

Not “how’s it going” text messages. Structured follow-up visits with lab review, body composition assessment, symptom review, and treatment plan adjustment. Your program should change over time because you’re changing over time.

An exit or maintenance strategy

At some point, most patients want to know what long-term looks like. Do they stay on the medication? Taper down? Move to a maintenance dose? These are individual decisions based on lab data, body composition trends, and how your body responds to changes. Any legitimate program should be having this conversation with you well before you consider stopping.

The specific patterns we see (and fix) most often

To make this concrete, here are the specific patient patterns we see repeatedly, and what we typically do about them:

Patient A: Started on semaglutide through a telehealth service. Six months in, weight has stalled at 30 lbs down (goal was 60 lbs), nausea has become chronic, energy is low. They don’t feel their program is working but are afraid to stop.

What we usually find: They’re at 1.7 mg semaglutide when they’d tolerate tirzepatide better. They haven’t had labs in six months. Their ferritin is under 30 and their B12 is borderline. Their protein intake is under 60 grams a day. Body composition shows they’ve lost 12 lbs of lean mass.

Patient B: On tirzepatide 10 mg for four months. Nausea has never resolved. They’ve stopped socializing because they can’t eat around people. Weight loss is minimal because they’re eating so little that their body is in metabolic conservation mode.

What we usually find: Dose went up too fast, they were never coached on injection timing, and they’ve been under-eating so severely that their thyroid function has downregulated.

Patient C: Lost 45 lbs on semaglutide over eight months. Now looking in the mirror and doesn’t recognize themselves. Skin looks thinner, muscle tone gone, energy is low. Family says they look “sick.”

What we usually find: They lost close to 20 lbs of lean mass along with the fat. Their labs show they’re now anemic and hormonally suppressed. They followed the medication protocol perfectly, but nobody managed anything else.

What to look for in a real GLP-1 program

If you’re evaluating a program — whether that’s us or someone else — here’s what should be present:

  • Baseline labs before starting. If they didn’t order labs, they’re not managing your care.
  • Body composition assessment, not just a scale. DEXA, bioimpedance, or InBody. Something.
  • Titration decisions made by a clinician who knows your case. Not automated by a schedule.
  • Nutrition guidance built in. Protein targets, micronutrient guidance, structured recommendations.
  • Structured follow-up. Real appointments at real intervals, not just “message us if you have questions.”
  • Long-term thinking. A plan for what happens at month 6, month 12, and beyond.
  • Ongoing lab monitoring. Labs at intervals, not just once at the start.
  • A prescriber you can actually talk to. By name. By video. Available for real conversation.

If your current program doesn’t include most of these, it’s not really a program. It’s a prescription with a shipping address.

When to consider transitioning

If any of the following describe your situation, you may be a good candidate for a comprehensive GLP-1 program:

  • You’ve been on a GLP-1 for more than three months and haven’t had lab work done
  • Weight loss has stalled and no one has adjusted anything
  • Nausea or side effects have persisted or intensified
  • Your energy has dropped significantly since starting
  • You suspect you’re losing muscle along with fat but nobody has measured it
  • You’re worried about long-term outcomes and don’t have a plan
  • You want a clinician who can actually see the whole picture

The transition from an ineffective GLP-1 program to a comprehensive one is straightforward. We evaluate what’s been done, order proper baseline workup, adjust the medication (or transition to a different GLP-1 if appropriate), and build out the missing pieces of the program.

The Tide’s approach

At The Tide, GLP-1 therapy is one of several treatment tools we use, not the entire clinic. We offer both tirzepatide and semaglutide, typically with a preference for tirzepatide based on the head-to-head trial data.

But the medication is only part of what we do. Every patient gets a comprehensive baseline workup, body composition assessment, and a structured program that includes nutrition, monitoring labs, and follow-up visits. We often prescribe supporting peptides when appropriate alongside the GLP-1 to preserve muscle and support recovery. And we build a long-term plan from day one — because the question isn’t just “how do I lose weight.” It’s “how do I lose fat, keep muscle, protect my long-term health, and know what happens after.”

If your current GLP-1 program isn’t working, or if you’re just starting and want to do it right the first time, we’re here. Schedule a consultation and let’s talk about where you actually are, what’s been missing, and what a real program looks like.

Keep reading

Related articles.